KIT D816V
Showing 1 - 25 of 1,940
(PROSPECTOR) Screening Study Evaluating Prevalence of KIT D816V
Recruiting
- Systemic Mast Cell Activation
- KIT D816V Mutation
- Screening
-
Boston, Massachusetts
- +1 more
May 5, 2022
Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients
Completed
- GIST
- Gastrointestinal Stromal Tumors
-
Beijing, China
- +2 more
Jun 1, 2022
Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Imatinib Mesylate
- Ipilimumab
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)
Not yet recruiting
- Advanced Systemic Mastocytosis
- (no location specified)
Nov 2, 2022
SSM, Mastocytosis, Indolent, Mastocytosis, Systemic Trial in United States (CGT9486 Tablets, Placebo Tablets)
Recruiting
- SSM
- +3 more
- CGT9486 Tablets
- Placebo Tablets
-
Clearwater, Florida
- +5 more
Apr 14, 2022
Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Tumor (SM-AHN), Mast Cell Leukemia (MCL) Trial in
Recruiting
- Advanced Systemic Mastocytosis (AdvSM)
- +3 more
- CGT9486 tablets
-
Duarte, California
- +10 more
Jul 8, 2022
Indolent Systemic Mastocytosis Trial in Worldwide (Avapritinib, Placebo)
Active, not recruiting
- Indolent Systemic Mastocytosis
- Avapritinib
- Placebo
-
Birmingham, Alabama
- +48 more
Jan 19, 2022
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor
Active, not recruiting
- Advanced Systemic Mastocytosis
- +3 more
-
Stanford, California
- +31 more
Mar 25, 2022
Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial
Completed
- Aggressive Systemic Mastocytosis
- +3 more
-
Stanford, California
- +10 more
Jan 12, 2023
Advanced Malignant Tumor, BRAF Gene Mutation, Metastatic Malignant Tumor Trial in Houston (Crizotinib, Laboratory Biomarker
Completed
- Advanced Malignant Neoplasm
- +4 more
- Crizotinib
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2021
Mastocytosis Trial (masitinib (AB1010))
Completed
- Mastocytosis
- masitinib (AB1010)
- (no location specified)
Dec 8, 2018
Wound Healing Trial in China (Experimental: Investigational device: V.A.C. VERAFLO™ Dressing Kit, Active Comparator: Dressing
Recruiting
- Wound Healing
- Experimental: Investigational device: V.A.C. VERAFLO™ Dressing Kit
- Active Comparator: Dressing Name: Negative pressure wound drainage material
-
Hefei, Anhui, China
- +3 more
Jun 5, 2023
Esophageal Tumors Trial (KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method))
Not yet recruiting
- Esophageal Neoplasms
- KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method)
- (no location specified)
Dec 25, 2022
Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations
Not yet recruiting
- Gastrointestinal Stromal Tumors
- +2 more
- (no location specified)
Jul 15, 2022
Validation of the European Oncology Quality of Life Toolkit
Not yet recruiting
- Cancer
- +2 more
- Administration of the EUonQoL-Kit - Active Treatment questionnaire
- +2 more
-
Tirana, Albania
- +44 more
Jul 17, 2023
Lung Cancer, Surgery, Recurrence Trial in Taichung (Early-stage lung cancer prognostic kit -- ELISA, Early-stage lung cancer
Recruiting
- Lung Cancer
- +2 more
- Early-stage lung cancer prognostic kit -- ELISA
- Early-stage lung cancer prognostic kit -- IHC
-
Taichung, TaiwanChung Shan Medical University Hospital
Sep 28, 2022
Indolent Systemic Mastocytosis Trial in France, Germany, United States (Masitinib, Placebo, Best Supportive Care)
Recruiting
- Indolent Systemic Mastocytosis
- Masitinib
- +2 more
-
Rochester, Minnesota
- +6 more
Nov 29, 2021
Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome Trial in Worldwide (BLU-263, Placebo)
Recruiting
- Indolent Systemic Mastocytosis
- Monoclonal Mast Cell Activation Syndrome
- BLU-263
- Placebo
-
Palo Alto, California
- +33 more
Jul 27, 2022
Colorectal Cancer Trial in Dublin (Behaviorally enhanced reminder letter)
Completed
- Colorectal Cancer
- Behaviorally enhanced reminder letter
-
Dublin, IrelandNational Screening Service
Nov 8, 2022
Cartilage Disease Trial in London, Wakefield (BioPoly RS Partial Resurfacing Patella Implant)
Recruiting
- Cartilage Disease
- BioPoly RS Partial Resurfacing Patella Implant
-
London, England, United Kingdom
- +1 more
Jul 18, 2022
Onco-liq: Kit for Breast Cancer Diagnosis.
Recruiting
- Breast Cancer
- Onco-liq: kit for breast cancer diagnosis.
-
Caba, Buenos Aires, ArgentinaHospital Militar Central
Jan 12, 2022
A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia
Not yet recruiting
- C-KIT Mutation
- (no location specified)
Nov 2, 2023